5:25 PM
 | 
Sep 12, 2013
 |  BC Extra  |  Financial News

Protalix raises $60 million note deal

Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX) raised $60 million in a note deal with institutional investors late Thursday. The 4.5% convertible notes mature on Sept. 15, 2018, and...

Read the full 125 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >